- Home
- MTEK vs AEON Comparison
MTEK vs AEON Comparison
Compare MTEK & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEK
- AEON
- Stock Information
- Founded
- MTEK 2008
- AEON N/A
- Country
- MTEK Israel
- AEON United States
- Employees
- MTEK N/A
- AEON N/A
- Industry
- MTEK
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- MTEK
- AEON Health Care
- Exchange
- MTEK Nasdaq
- AEON Nasdaq
- Market Cap
- MTEK 15.1M
- AEON 13.5M
- IPO Year
- MTEK 2022
- AEON N/A
- Fundamental
- Price
- MTEK $1.33
- AEON $0.89
- Analyst Decision
- MTEK
- AEON Strong Buy
- Analyst Count
- MTEK 0
- AEON 1
- Target Price
- MTEK N/A
- AEON $7.20
- AVG Volume (30 Days)
- MTEK 67.6K
- AEON 361.1K
- Earning Date
- MTEK 09-26-2025
- AEON 11-12-2025
- Dividend Yield
- MTEK N/A
- AEON N/A
- EPS Growth
- MTEK N/A
- AEON N/A
- EPS
- MTEK N/A
- AEON N/A
- Revenue
- MTEK $3,375,716.00
- AEON N/A
- Revenue This Year
- MTEK N/A
- AEON N/A
- Revenue Next Year
- MTEK N/A
- AEON N/A
- P/E Ratio
- MTEK N/A
- AEON N/A
- Revenue Growth
- MTEK N/A
- AEON N/A
- 52 Week Low
- MTEK $1.31
- AEON $0.38
- 52 Week High
- MTEK $6.47
- AEON $64.80
- Technical
- Relative Strength Index (RSI)
- MTEK 28.03
- AEON 46.76
- Support Level
- MTEK $1.63
- AEON $0.83
- Resistance Level
- MTEK $1.80
- AEON $1.09
- Average True Range (ATR)
- MTEK 0.14
- AEON 0.10
- MACD
- MTEK -0.01
- AEON -0.01
- Stochastic Oscillator
- MTEK 5.93
- AEON 14.29
About MTEK Maris-Tech Ltd.
Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.